Literature DB >> 22730015

Nutrition therapy issues in esophageal cancer.

Keith R Miller1, Matthew C Bozeman.   

Abstract

Esophageal cancer has traditionally been a disease with poor long term outcomes in terms of both survival and quality of life. In combination with surgical and pharmacologic therapy, nutrition support has been demonstrated to improve patient tolerance of treatment, quality of life, and longterm outcomes. An aggressive multi-disciplinary approach is warranted with nutrition support remaining a cornerstone in management. Historically, nutrition support has focused on adequate caloric provision to prevent weight loss and allow for tolerance of treatment regimens. Alterations in metabolism occur in these patients making their use of available calories inefficient and the future of nutritional support may lie in the ability to alter this deranged metabolism. The purpose of this article is to review the current literature surrounding the etiology, treatment, and role of nutrition support in improving outcomes in esophageal cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22730015     DOI: 10.1007/s11894-012-0272-6

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  102 in total

Review 1.  The causes and consequences of cancer-associated malnutrition.

Authors:  Eric Van Cutsem; Jann Arends
Journal:  Eur J Oncol Nurs       Date:  2005       Impact factor: 2.398

2.  Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus.

Authors:  Kenneth K Wang; Richard E Sampliner
Journal:  Am J Gastroenterol       Date:  2008-03       Impact factor: 10.864

3.  Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure.

Authors:  Noritoshi Nagaya; Junji Moriya; Yoshio Yasumura; Masaaki Uematsu; Fumiaki Ono; Wataru Shimizu; Kazuyuki Ueno; Masafumi Kitakaze; Kunio Miyatake; Kenji Kangawa
Journal:  Circulation       Date:  2004-11-29       Impact factor: 29.690

4.  Curative effect comparison between Ivor-Lewis esophagectomy and left transthoracic esophagectomy in treatment of middle thoracic esophagus carcinoma.

Authors:  Liang Song; Ying Liu; Zhou Wang; Wan-Gang Ren; Xiang-Yan Liu
Journal:  Hepatogastroenterology       Date:  2012-05

5.  An assessment of aetiology-based guidelines for the management of nausea and vomiting in patients with advanced cancer.

Authors:  Jeffrey Stephenson; Andrew Davies
Journal:  Support Care Cancer       Date:  2005-10-15       Impact factor: 3.603

6.  Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis.

Authors:  Edward B Rubenstein; Douglas E Peterson; Mark Schubert; Dorothy Keefe; Deborah McGuire; Joel Epstein; Linda S Elting; Philip C Fox; Catherine Cooksley; Stephen T Sonis
Journal:  Cancer       Date:  2004-05-01       Impact factor: 6.860

7.  Percutaneous endoscopic jejunostomy and jejunal extension tube through percutaneous endoscopic gastrostomy: a retrospective analysis of success, complications and outcome.

Authors:  Y Zopf; C Rabe; T Bruckmoser; J Maiss; E G Hahn; D Schwab
Journal:  Digestion       Date:  2009-03-12       Impact factor: 3.216

8.  Benefits versus risks: a prospective audit. Feeding jejunostomy during esophagectomy.

Authors:  Vikas Gupta
Journal:  World J Surg       Date:  2009-07       Impact factor: 3.352

Review 9.  Growth hormone resistance in chronic heart failure and its therapeutic implications.

Authors:  Mariantonietta Cicoira; Paul R Kalra; Stefan D Anker
Journal:  J Card Fail       Date:  2003-06       Impact factor: 5.712

10.  Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.

Authors:  W D Dewys; C Begg; P T Lavin; P R Band; J M Bennett; J R Bertino; M H Cohen; H O Douglass; P F Engstrom; E Z Ezdinli; J Horton; G J Johnson; C G Moertel; M M Oken; C Perlia; C Rosenbaum; M N Silverstein; R T Skeel; R W Sponzo; D C Tormey
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

View more
  16 in total

1.  Physical decline and its implications in the management of oesophageal and gastric cancer: a systematic review.

Authors:  Linda O'Neill; Jonathan Moran; Emer M Guinan; John V Reynolds; Juliette Hussey
Journal:  J Cancer Surviv       Date:  2018-05-23       Impact factor: 4.442

Review 2.  Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends.

Authors:  Peter S N van Rossum; Nadia Haj Mohammad; Frank P Vleggaar; Richard van Hillegersberg
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-12-13       Impact factor: 46.802

Review 3.  Cachexia in patients with oesophageal cancer.

Authors:  Poorna Anandavadivelan; Pernilla Lagergren
Journal:  Nat Rev Clin Oncol       Date:  2015-11-17       Impact factor: 66.675

Review 4.  Surgical indications and optimization of patients for resectable esophageal malignancies.

Authors:  Joshua C Grimm; Vicente Valero; Daniela Molena
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

5.  Long-term impact of prognostic nutritional index in cervical esophageal squamous cell carcinoma patients undergoing definitive radiotherapy.

Authors:  Yaqing Dai; Xiaobin Fu; Tingting Li; Qiwei Yao; Liyu Su; Huiyan Su; Jiancheng Li
Journal:  Ann Transl Med       Date:  2019-04

6.  Pretreatment nutritional risk scores and performance status are prognostic factors in esophageal cancer patients treated with definitive chemoradiotherapy.

Authors:  Tao Song; Qiuyan Wan; Wenke Yu; Jianbo Li; Shaohua Lu; Chen Xie; Hongqing Wang; Min Fang
Journal:  Oncotarget       Date:  2017-10-19

7.  Impact Exerted by Nutritional Risk Screening on Clinical Outcome of Patients with Esophageal Cancer.

Authors:  Rui Wang; Hongfei Cai; Yang Li; Caiwen Chen; Youbin Cui
Journal:  Biomed Res Int       Date:  2018-03-27       Impact factor: 3.411

8.  Impact of type 2 diabetes mellitus on short-term and long-term outcomes of patients with esophageal squamous cell cancer undergoing resection: a propensity score analysis.

Authors:  Wang Yao; Yuqi Meng; Mingjian Lu; Wenzhe Fan; Jinhua Huang; Jiaping Li; Zhihua Zhu
Journal:  Cancer Commun (Lond)       Date:  2018-04-27

9.  Safety and efficacy of oesophageal stenting with simultaneous percutaneous endoscopic gastrostomy as a supplementary feeding route in unresectable proximal oesophageal cancer.

Authors:  Janusz R Włodarczyk; Jarosław Kużdżał
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2018-02-07       Impact factor: 1.195

10.  Selection and optimization of nutritional risk screening tools for esophageal cancer patients in China.

Authors:  Wen Dong; Xiguang Liu; Shunfang Zhu; Di Lu; Kaican Cai; Ruijun Cai; Qing Li; Jingjing Zeng; Mei Li
Journal:  Nutr Res Pract       Date:  2019-08-28       Impact factor: 1.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.